Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 137 are a BUY (52.29%), 106 are a HOLD (40.46%), 19 are a SELL (7.25%).
Analyst David Risinger, currently employed at LEERINK, carries an average stock price target met ratio of 74.78% that have a potential upside of 20.17% achieved within 253 days.
David Risinger’s has documented 496 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JNJ, Johnson & Johnson at 13-May-2025.
Analyst best performing recommendations are on BHC (BAUSCH HEALTH COMPANIES).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 1/21/2016. The price target of $35 was fulfilled within 1 day with a profit of $1.31 (3.89%) receiving and performance score of 38.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$205
$15.98 (8.45%)
$215
2 months 23 days ago
(14-May-2025)
12/14 (85.71%)
$27.59 (15.55%)
285
Buy
$216
$26.98 (14.27%)
$214
3 months 8 days ago
(29-Apr-2025)
23/26 (88.46%)
$22.49 (11.62%)
431
Buy
$250
$60.98 (32.26%)
$241
3 months 9 days ago
(28-Apr-2025)
12/18 (66.67%)
$57.66 (29.98%)
526
Buy
$240
$50.98 (26.97%)
$210
5 months 1 days ago
(05-Mar-2025)
7/8 (87.5%)
$28.46 (13.45%)
474
Hold
$223
$33.98 (17.98%)
$191
5 months 2 days ago
(04-Mar-2025)
3/4 (75%)
$15.71 (7.58%)
443
Which stock is David Risinger is most bullish on?
What Year was the first public recommendation made by David Risinger?